-20%
Back to products
Lamivudine Stavudine Nevirapine Tablets
Price range: $6.30 through $18.89
Artemether Lumefantrine Tablets
Price range: $20.03 through $60.09
Available Options
| Tablets | Price | Description | Quantity | |
|---|---|---|---|---|
| 60 Tablet | Original price was: $25.00.$20.03Current price is: $20.03. | $0.33/piece | ||
| 120 Tablets | Original price was: $50.00.$40.06Current price is: $40.06. | $0.33/piece | ||
| 180 Tablets | Original price was: $70.00.$60.09Current price is: $60.09. | $0.33/piece |
Nevirapine is a non-nucleoside reverse transcriptase inhibitor specific for HIV-1 reverse transcriptase.
Description
| Packaging Size | 10*6tablet |
| Brand | lumetherforte DT |
| Manufacturer | themis |
| Compo sition | Artemether Lume fantrine |
| Treatment | antimalarialdrugs |
| Prescription/Nonprescription | Prescription |
| Form | Tablet |
| Country of Origin | Made in India |
Additional information
| Tablets |
120 Tablets ,180 Tablets ,60 Tablet |
|---|
Reviews (0)
Related products
Alphalan 5 Mg (Melphalan)
In stock
Price range: $239.00 through $855.00
Select options
This product has multiple variants. The options may be chosen on the product page
Alphalan 5 Mg (Melphalan)
In stock
Price range: $75.00 through $265.40
Select options
This product has multiple variants. The options may be chosen on the product page
Azicip 250mg
In stock
Price range: $15.00 through $111.00
Select options
This product has multiple variants. The options may be chosen on the product page
Iversun 12mg
In stock
Price range: $55.00 through $535.00
Select options
This product has multiple variants. The options may be chosen on the product page
Labedra 20
In stock
Price range: $70.80 through $306.00
Select options
This product has multiple variants. The options may be chosen on the product page
Shelcal 500 Calcium+Vitamin D3 Tablet
In stock
Original price was: $2.00.$1.40Current price is: $1.40.
Systane Hydration Lubricant Eye Drop
In stock
Original price was: $6.00.$5.50Current price is: $5.50.
Reviews
There are no reviews yet.